US2395665A - Agents for protecting against light of short wave length - Google Patents
Agents for protecting against light of short wave length Download PDFInfo
- Publication number
- US2395665A US2395665A US481434A US48143443A US2395665A US 2395665 A US2395665 A US 2395665A US 481434 A US481434 A US 481434A US 48143443 A US48143443 A US 48143443A US 2395665 A US2395665 A US 2395665A
- Authority
- US
- United States
- Prior art keywords
- wave length
- skin
- short wave
- against light
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 description 17
- 239000000203 mixture Substances 0.000 description 16
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 12
- -1 fatty acid esters Chemical class 0.000 description 12
- 239000006071 cream Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000006210 lotion Substances 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 7
- 235000019645 odor Nutrition 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003444 anaesthetic effect Effects 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229940064734 aminobenzoate Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 150000000211 1-dodecanols Chemical class 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- XXXHSQBVHSJQKS-UHFFFAOYSA-N amino benzoate Chemical compound NOC(=O)C1=CC=CC=C1 XXXHSQBVHSJQKS-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 108010052322 limitin Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
Definitions
- This invention relates to improvements in compositions for use as coatings or films for protection of the skin against light of short wave length. It more particularly relates to novel compositions of matter containing substances having the property of absorbing light of short wave length or transforming its wave length to non-burning length; and to substances comprising the active ingredients of these compositions.
- the compounds described and claimed herein are particularly characterized by their insolubility in water. so that they are preferably to be applied to the point of use in the form of lotions. emulsions, creams and the like, as distinguished from pure solutions, and the invention also is directed to the formation of such compositions and the compositions themselves.
- the rays to which this treatment is paiticularly directed are themselves of a wave length of talline form, since crystallization will tend materially to interrupt the film formation, and solubility in convenient and non-toxic carriers.
- such materials must themselves be of a completely non-toxic character, the-term nontoxic being meant to include the elimination of any undesired efiect upon the skin, including irritation, infection and anesthesia.
- the compound used may be effective in relatively small concentrations, both from the standpoint of expens of. the product and from the general undesirability of applying high concentrations of foreign substances to the surface of the skin.
- the materials used are desirably colorless and tasteless and more particularly, since they are intended for cosmetic use, are preferably entirely without odor.
- Our present compounds have been found to be highly effective in the interception and transformation of light of short wavelength, particularly when applied to the skin of a human being.
- These compounds comprise higher fatty acid esters of para amino benzoic acid, characterized by an essential lack of anesthetic effect, ready emulsifiability. naturally rendering their incorporation in creams and lotions relatively easy, waxy as opposed to crystalline composition, also contributing to ease of combination into lotions and creams, a complete lack of odor or any other undesired physical property when spread on the surface of the skin. and high screening properties in small concentrations in thin films.
- More particularly our invention includes the fatty alcohol esters of para amino benzoic acid containing fourteen or more carbon atoms in the fatty alcohol carbon chain, especially desirable compounds being myristyl, cetyl. oleyl and stearyl alcohols. as well as mixed alcohols obtained from hydro enated natural oil which can be esterified with the formation of waxes of varying hardness.
- a particular advantage of this group of compounds over the esters of the lower fatty acids of the same series lies in the fact that they are completely non-anesthetic. as opposed to ethyl, propvhbutyl, and amyl compounds. They are substantially completely insoluble in water as opposed to the compounds of the series from methyl to amyl. which is a very desirable property. particularly when used in tropical countries where the probl m of pers iration must be consi ered. and in use by swimmers, and they are completely without odor, as opposed to the capryl. decyl and lauryl com ounds.
- a proximat ly molecular ro ortions of myristyl. oleyl. stearyl, or such mixed alcohols obtained from hydrogenated natural oil, such as cocoanut and whale oils, which are free of the undesired lower fatty components. can be substituted with the formation of waxes of varying hardness. all of which may be emulsified directly with water and have valuable light absorbing properties.
- one of such forms is a liquid lotion which
- the r si ue of the I may suitably be made by combining with the finished product from the example above.
- dl-ethyl amino stearyl lactate as an emulsifying agent and boiling water. whereby the combination takes place at a temperature near the boiling point of water. On cooling this mixture is awhite creamy lotion which will pour readily and is suitable for bottling, for storage or shipment purposes.
- An example of such a lotion and the method of making it is as follows:
- Example II -5 parts of para amino cetyl benzoate are melted together with 4 parts of di-ethyl amino stearyl lactate and the mixture is heated to approximately C. To this is added, while stirring, 91 parts of boiling water. The mixture is allowed to cool to room temperature and when so cooled is ready for use by application directly to the skin, -or may be bottled for shipment and storage.
- the ma terial in the form of a cream adapted for application to the skin.
- the cream may preferably be obtained by addition of a thickening agent 'to the composition of the lotion, and further if it is desired to provide a cream of oily character. the addition of small quantities of mineral or vegetable oils will achieve this end.
- An example of a cream is as follows:
- Example III -5 parts para amino cetyl benzoate, 4 parts of di-ethyl amino stearyl lactate, and 3 parts of monoglyceryl stearate are melted together and heated to 90 C. To this is added. while stirring, 88 parts of boiling water. The mixture when cooled to room temperature is a non-greasy. stable cream.
- An advantage of the compounds described containing the higher fatty alcohol carbon chains is that such compounds, and particularly the cetyl compound, have a very desirable healing and emollient action upon the skin. This action helps to protect the skin from the irritating effects of the sun. These compounds are thus especially suitable in the making of creams. it is also characteristic of the compounds described that they do not tend to turn rancid.
- a preparation for protecting the skin against light of short wave length containing as its active ingredient a non-crystalline, odorless. nonanesthetic. substantially water insoluble ester of para amino benzoic acid and a ,fatty alcohol chosen from the class consisting of myristyl. cetyl, and stearyl alcohols.
- composition for protecting the skin against light of short Wave length containing as its active ingredient myristyl para amino benzoate.
- composition for protecting the skin against light of short Wave length containing as its active ingredient cetyl para amino benzoat-e.
- composition for protecting the skin against light of short wave length containing as its active ingredient stearyl para amino benzoate.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
' Patented Feb. 26, 1946 AGENTS FOR PROTECTING AGAINST LIGHT OF SHORT WAVE LENGTH Samuel Isermann, Tucson, Ariz., and Ernst. Ohlsson, Short Hills, N. J.
No Drawing. Application April 1, 1943. Serial No. 481,434
4 Claims. (01. 167-90) This invention relates to improvements in compositions for use as coatings or films for protection of the skin against light of short wave length. It more particularly relates to novel compositions of matter containing substances having the property of absorbing light of short wave length or transforming its wave length to non-burning length; and to substances comprising the active ingredients of these compositions.
The compounds described and claimed herein are particularly characterized by their insolubility in water. so that they are preferably to be applied to the point of use in the form of lotions. emulsions, creams and the like, as distinguished from pure solutions, and the invention also is directed to the formation of such compositions and the compositions themselves.
The application is a continuation in part of our copending application, Serial No. 303,536, filed November 9, 1939.
It is well known that over-exposure of the body to direct radiation from the sun is apt to cause acute and chronic dermatitis, blisters, severe burns, as well as such disagreeable minor effects as mottling of the skin, pigment anomalies, freckles, etc. Th development of a pleasin tan coloration of the skin is much sought after but can be obtained only by allowing the skin gradually to develop its own protective pigmentation by even deposits of melanin. I
The basis of approach in preventing solar or light wave dermatitis is that it is desirable to provide a screen which will affect impinging rays in a manner to render their contact with the surface of the skin harmless.
which actually intercepts or absorbs the harmful rays, or by the use of a screen which modifies the wave lengths of the harmful rays to render them harmless, and is preferably obtained by use of a This desirable re- .sult may be obtained either by the use of a screen.
screen which simultaneously achieves both of these desirable objects.
The rays to which this treatment is paiticularly directed are themselves of a wave length of talline form, since crystallization will tend materially to interrupt the film formation, and solubility in convenient and non-toxic carriers. In addition such materials must themselves be of a completely non-toxic character, the-term nontoxic being meant to include the elimination of any undesired efiect upon the skin, including irritation, infection and anesthesia. In addition it is desirable that the compound used may be effective in relatively small concentrations, both from the standpoint of expens of. the product and from the general undesirability of applying high concentrations of foreign substances to the surface of the skin. In addition the materials used are desirably colorless and tasteless and more particularly, since they are intended for cosmetic use, are preferably entirely without odor. In fact not only must unpleasant odors be eliminated from consideration, but since the type of compound used is commonly employed by both sexes, particularly by soldiers operating in tropical or arctic climates, the presence of perfumery type odors is quite as undesirable as those which are unpleasant to the sense of smell.
It has been found that many substances heretofore' proposed for the purpose mentioned possess one or more of the various difficulties and disabilities outlined above. Such materials as benzyl cinamate, benzyl salicylate, menthol salicylate. aesculetine and the like, though apparently capable on theoretical grounds of absorbing a substantial amount of ultra-violet light must be used, in order to be eifective at all, in concentrations as high as 10%, in which concentrations they are expensive and liable to cause serious physiological disturbances when applied to the body. Such substances as ethyl, propyl, butyl, and amyl esters of para amino benzoic acid have been suggested for the purpose but are found to cause-so high an anesthetic effect (they are in fact indicated as local anesthetics), that they are substantially useless for ultra-violet ray interception purposes. Decyl and lauryl alcohols when condensed with para amino benzoic acid are also unavailable because'of substantial odors which these compounds have even when present in very small concentrations.
Our present compounds have been found to be highly effective in the interception and transformation of light of short wavelength, particularly when applied to the skin of a human being. These compounds comprise higher fatty acid esters of para amino benzoic acid, characterized by an essential lack of anesthetic effect, ready emulsifiability. naturally rendering their incorporation in creams and lotions relatively easy, waxy as opposed to crystalline composition, also contributing to ease of combination into lotions and creams, a complete lack of odor or any other undesired physical property when spread on the surface of the skin. and high screening properties in small concentrations in thin films.
More particularly our invention includes the fatty alcohol esters of para amino benzoic acid containing fourteen or more carbon atoms in the fatty alcohol carbon chain, especially desirable compounds being myristyl, cetyl. oleyl and stearyl alcohols. as well as mixed alcohols obtained from hydro enated natural oil which can be esterified with the formation of waxes of varying hardness.
A particular advantage of this group of compounds over the esters of the lower fatty acids of the same series lies in the fact that they are completely non-anesthetic. as opposed to ethyl, propvhbutyl, and amyl compounds. They are substantially completely insoluble in water as opposed to the compounds of the series from methyl to amyl. which is a very desirable property. particularly when used in tropical countries where the probl m of pers iration must be consi ered. and in use by swimmers, and they are completely without odor, as opposed to the capryl. decyl and lauryl com ounds. It will a so be seen t at since it is the purpose of this invention to provide materials of a generally waxy charact r which may suitably be incorporated into creams. lotions or the like. derivatives or com ounds of this class, substituted either in the fatty acid portion or in the amino benzoate ortion of the compound which are of a normally cr stalline nature. may not be used as effectively as the compounds them selves.
Our compounds may preferably be repared by alcoholosis. an exam le of which follows. though it is not intended to be limitin in any respect.
Exam le I. 105 gm. of cetvl alcohol and 2.3
am. of 50% solution of potassiu hydroxide are heated under vacuum with d stillation of water until no more water distills. 66 m, of ethyl para. amino benzoate are added /and the mixture heated to a temperature of ap roximately 135 C. Distillation of ethyl alcohol be ins and continues wi h radual increase in temperature to about 200 C. or until approximately 15 cc. of ethyl alcohol have distilled over, potassium hydroxide remaining may be neutralized in any suitable manner. Addition of a hi her fatty acid. such as stearic acid. until the neutral point is reached. leaves the final product in a form readily emulsifiable with water. due to the presence of potassium stearate which acts as an emulsifier. In the process of this example a proximat ly molecular ro ortions of myristyl. oleyl. stearyl, or such mixed alcohols obtained from hydrogenated natural oil, such as cocoanut and whale oils, which are free of the undesired lower fatty components. can be substituted with the formation of waxes of varying hardness. all of which may be emulsified directly with water and have valuable light absorbing properties.
As pointed out above. it is desirable to incorporate the compounds of our invention into various form more suitable for direct action to the skin; one of such forms is a liquid lotion which The r si ue of the I may suitably be made by combining with the finished product from the example above. dl-ethyl amino stearyl lactate as an emulsifying agent and boiling water. whereby the combination takes place at a temperature near the boiling point of water. On cooling this mixture is awhite creamy lotion which will pour readily and is suitable for bottling, for storage or shipment purposes. An example of such a lotion and the method of making it is as follows:
Example II .-5 parts of para amino cetyl benzoate are melted together with 4 parts of di-ethyl amino stearyl lactate and the mixture is heated to approximately C. To this is added, while stirring, 91 parts of boiling water. The mixture is allowed to cool to room temperature and when so cooled is ready for use by application directly to the skin, -or may be bottled for shipment and storage.
In some cases it is desirable to provide the ma terial in the form of a cream adapted for application to the skin. The cream may preferably be obtained by addition of a thickening agent 'to the composition of the lotion, and further if it is desired to provide a cream of oily character. the addition of small quantities of mineral or vegetable oils will achieve this end. An example of a cream is as follows:
Example III .-5 parts para amino cetyl benzoate, 4 parts of di-ethyl amino stearyl lactate, and 3 parts of monoglyceryl stearate are melted together and heated to 90 C. To this is added. while stirring, 88 parts of boiling water. The mixture when cooled to room temperature is a non-greasy. stable cream.
The addition of one part or more of any desired mineral or vegetable oil suitable for application to the skin while the above mixture is hot will change the character of the cream from non-greasy to more or less oily.
An advantage of the compounds described containing the higher fatty alcohol carbon chains is that such compounds, and particularly the cetyl compound, have a very desirable healing and emollient action upon the skin. This action helps to protect the skin from the irritating effects of the sun. These compounds are thus especially suitable in the making of creams. it is also characteristic of the compounds described that they do not tend to turn rancid.
We claim:
1. A preparation for protecting the skin against light of short wave length containing as its active ingredient a non-crystalline, odorless. nonanesthetic. substantially water insoluble ester of para amino benzoic acid and a ,fatty alcohol chosen from the class consisting of myristyl. cetyl, and stearyl alcohols.
2. A composition for protecting the skin against light of short Wave length containing as its active ingredient myristyl para amino benzoate.
3. A composition for protecting the skin against light of short Wave length containing as its active ingredient cetyl para amino benzoat-e.
4. A composition for protecting the skin against light of short wave length containing as its active ingredient stearyl para amino benzoate.
SAMUEL ISERMANN. ERNST OHLSSON.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US481434A US2395665A (en) | 1943-04-01 | 1943-04-01 | Agents for protecting against light of short wave length |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US481434A US2395665A (en) | 1943-04-01 | 1943-04-01 | Agents for protecting against light of short wave length |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2395665A true US2395665A (en) | 1946-02-26 |
Family
ID=23911925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US481434A Expired - Lifetime US2395665A (en) | 1943-04-01 | 1943-04-01 | Agents for protecting against light of short wave length |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2395665A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3175950A (en) * | 1960-07-22 | 1965-03-30 | Armour Pharmaceutrical Company | Sunscreening preparations |
| US4136165A (en) * | 1976-04-23 | 1979-01-23 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic preparations with alkoxybenzoic acid esters as inflammation inhibitors and method |
| US4401649A (en) * | 1981-07-20 | 1983-08-30 | Polaroid Corporation | Sunscreen method |
-
1943
- 1943-04-01 US US481434A patent/US2395665A/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3175950A (en) * | 1960-07-22 | 1965-03-30 | Armour Pharmaceutrical Company | Sunscreening preparations |
| US4136165A (en) * | 1976-04-23 | 1979-01-23 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic preparations with alkoxybenzoic acid esters as inflammation inhibitors and method |
| US4401649A (en) * | 1981-07-20 | 1983-08-30 | Polaroid Corporation | Sunscreen method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4009254A (en) | Topical compositions | |
| US4612331A (en) | Skin treatment composition | |
| US4355046A (en) | Dermatologic and cosmetic ointment base | |
| CA1138739A (en) | Make up remover for the face and eyes | |
| CA2239665C (en) | Dihydroxyacetone formulations having improved stability and enhanced delivery | |
| US5503825A (en) | Lip balm composition | |
| DE2719533C2 (en) | ||
| JPS60190708A (en) | Absorbent for ultraviolet radiation having long wavelength | |
| JPH062658B2 (en) | Sunlight filtering composition | |
| EP0738511B1 (en) | Use of silicone waxes containing ester functions as thickeners in oily media | |
| MXPA04002645A (en) | Sunscreen compositions. | |
| DE3836630A1 (en) | TRANSPARENT COSMETIC AGENT FOR THE REFLECTION OF INFRARED RADIATORS BASED ON TITANIUM DIOXIDE FLAKES AND ITS USE FOR THE PROTECTION OF HUMAN EPIDERMIS BEFORE INFRARED RADIATION | |
| CA2549725A1 (en) | A base composition for preparing multi-functional formulations for care and protection of the skin and hair | |
| JPH0421642B2 (en) | ||
| JP2001081024A (en) | Milky oil-in-water type emulsification composition and method for producing the same composition | |
| EP1430882B1 (en) | Combinations of antioxidants containing 6,7-disubstituted 2,2-dialkylchromanes or -chromenes | |
| CN112315820A (en) | Oil-in-water sunscreen emulsion and preparation method thereof | |
| US2395665A (en) | Agents for protecting against light of short wave length | |
| JP3220657B2 (en) | Sunscreen cosmetics | |
| US8383166B2 (en) | Stable hydrophobic topical herbal formulationn | |
| CA2524375A1 (en) | Topical composition for the treatment of skin disorders and methods of using the same | |
| JP3515154B2 (en) | Emulsified cosmetic | |
| JP7396060B2 (en) | Skin external preparations | |
| JP2001181174A (en) | Cosmetic composition | |
| JPH0615449B2 (en) | External water phase type cosmetics |